Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Benelli

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Breast Cancer Research : BCR|May 31, 2019
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trialLorenzo Rossi, Chiara Biagioni, Amelia McCartney, et al.
The Journal of Clinical Investigation|December 5, 2017
Differential impact of RB status on E2F1 reprogramming in human cancerChristopher McNair, Kexin Xu, Amy C Mandigo, et al.
Cancer Cell|October 12, 2016
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate CancerEtienne Dardenne, Himisha Beltran, Matteo Benelli, et al.
European Journal of Cancer (Oxford, England : 1990)|November 14, 2024
Radiomic features of primary retroperitoneal sarcomas: a prognostic studySandro Pasquali, Sara Iadecola, Andrea Vanzulli, et al.
The Journal of Clinical Investigation|March 10, 2020
Genome-wide plasma DNA methylation features of metastatic prostate cancerAnjui Wu, Paolo Cremaschi, Daniel Wetterskog, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2023
Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trialLuca Malorni, Giampaolo Bianchini, Roberta Caputo, et al.
ESMO Open|April 10, 2019
Benefit from anti-EGFRs in <i>RAS</i> and <i>BRAF</i> wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept studyChiara Cremolini, Matteo Benelli, Elisa Fontana, et al.
Nucleic Acids Research|December 20, 2022
CHD8 suppression impacts on histone H3 lysine 36 trimethylation and alters RNA alternative splicingEmanuela Kerschbamer, Michele Arnoldi, Takshashila Tripathi, et al.
Nature Medicine|February 9, 2016
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancerHimisha Beltran, Davide Prandi, Juan Miguel Mosquera, et al.
Haematologica|March 3, 2017
<i>CEBPA</i>-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological featuresFrancesco Mannelli, Vanessa Ponziani, Sara Bencini, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Breast Cancer Research : BCR|May 31, 2019
Clinical outcomes after palbociclib with or without endocrine therapy in postmenopausal women with hormone receptor positive and HER2-negative metastatic breast cancer enrolled in the TREnd trialLorenzo Rossi, Chiara Biagioni, Amelia McCartney, et al.
The Journal of Clinical Investigation|December 5, 2017
Differential impact of RB status on E2F1 reprogramming in human cancerChristopher McNair, Kexin Xu, Amy C Mandigo, et al.
Cancer Cell|October 12, 2016
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate CancerEtienne Dardenne, Himisha Beltran, Matteo Benelli, et al.
European Journal of Cancer (Oxford, England : 1990)|November 14, 2024
Radiomic features of primary retroperitoneal sarcomas: a prognostic studySandro Pasquali, Sara Iadecola, Andrea Vanzulli, et al.
The Journal of Clinical Investigation|March 10, 2020
Genome-wide plasma DNA methylation features of metastatic prostate cancerAnjui Wu, Paolo Cremaschi, Daniel Wetterskog, et al.
European Journal of Cancer (Oxford, England : 1990)|April 1, 2023
Serum thymidine kinase activity in patients with HR-positive/HER2-negative advanced breast cancer treated with ribociclib plus letrozole: Results from the prospective BioItaLEE trialLuca Malorni, Giampaolo Bianchini, Roberta Caputo, et al.
ESMO Open|April 10, 2019
Benefit from anti-EGFRs in <i>RAS</i> and <i>BRAF</i> wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept studyChiara Cremolini, Matteo Benelli, Elisa Fontana, et al.
Nucleic Acids Research|December 20, 2022
CHD8 suppression impacts on histone H3 lysine 36 trimethylation and alters RNA alternative splicingEmanuela Kerschbamer, Michele Arnoldi, Takshashila Tripathi, et al.
Nature Medicine|February 9, 2016
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancerHimisha Beltran, Davide Prandi, Juan Miguel Mosquera, et al.
Haematologica|March 3, 2017
<i>CEBPA</i>-double-mutated acute myeloid leukemia displays a unique phenotypic profile: a reliable screening method and insight into biological featuresFrancesco Mannelli, Vanessa Ponziani, Sara Bencini, et al.
Pageof 9